Bio Tech
NeOnc's Unique Path to IPO: A Biotech Game Changer
NeOnc, Technologies Holdings, Inc., a biotech company revolutionizing the treatment of brain cancer with its innovative delivery method, is breaking new ground once again by closing its most recent funding round at a $220 million valuation.
How Is Quality Ensured in Lot Release Testing?
This article explores how quality is ensured in lot release testing, the processes involved, and the impact of these measures on the biopharmaceutical industry.
Why Is Leadership Important in Biosimilar Manufacturing?
This article explores why leadership is essential in biosimilar manufacturing and how it influences the success of these complex products.
FDA Pauses BioNTech's Chinese-Licensed Cancer Drug Trial Over Safety Issues
The FDA has paused BioNTech's breast and lung cancer trial involving licensed treatment from Chinese biotech MediLink Therapeutics Ltd., citing safety concerns.